{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:04:12Z","timestamp":1793318652666,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate whether US findings indicating MSU deposits and US-detected inflammation (i.e. power Doppler signal) predict gout flares over 12\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Gout patients on urate-lowering therapy for at least the preceding 6\u2009months were enrolled consecutively in this 12-month prospective, observational, single-centre study. A nested case\u2013control analysis was performed. Cases were participants with at least one flare in the follow-up period, while controls did not self-report any gout flare. The US assessment included elbows, wrists, second MCP joints, knees, ankles, and first MTP joints. The US findings indicating MSU deposits [i.e. aggregates, double contour (DC) sign and tophi] were identified as present\/absent according to the Outcome Measure in Rheumatology definitions. Power Doppler signal was scored semiquantitatively. Summated scores were calculated for each US finding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-one gout participants were enrolled, and 71 completed the study. Thirty (42.3%) of 71 participants experienced at least one flare over 12\u2009months, with a median of 2.0 flares. Cases had a greater US burden of MSU deposits (6.7\u2009\u00b1\u20094.7 vs 2.9\u2009\u00b1\u20092.6, P\u2009=\u20090.01) and power Doppler signal (3.73\u2009\u00b1\u20093.53 vs 0.82\u2009\u00b1\u20091.44, P\u2009&amp;lt;\u20090.01) than controls, at baseline. The baseline US scores indicating MSU deposits and US-detected inflammation were significantly associated with the occurrence (total MSU score, adjusted odds ratio:1.75, 95% CI: 1.26, 2.43; power Doppler score, adjusted odds ratio: 1.63, 95% CI: 1.12, 2.40) and the number (total MSU score, adjusted incidence risk ratio: 1.17, 95% CI: 1.08, 1.26; power Doppler score, adjusted incidence risk ratio: 1.29, 95% CI: 1.19, 1.40) of flares over 12\u2009months in multivariate analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Baseline US findings indicating MSU deposits and US-detected inflammation are independent predictors of gout flares over 12\u2009months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac367","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T10:39:36Z","timestamp":1659523176000},"page":"1108-1116","source":"Crossref","is-referenced-by-count":26,"title":["Ultrasonography\u2002in the prediction of gout flares: a 12-month prospective observational study"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-8197","authenticated-orcid":false,"given":"Edoardo","family":"Cipolletta","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Rheumatology Unit, Polytechnic University of Marche , Ancona, Italy"},{"name":"Academic Rheumatology, University of Nottingham , Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[{"name":"Academic Rheumatology, University of Nottingham , Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Di Battista","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Rheumatology Unit, Polytechnic University of Marche , Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Grassi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Rheumatology Unit, Polytechnic University of Marche , Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-7784","authenticated-orcid":false,"given":"Emilio","family":"Filippucci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Rheumatology Unit, Polytechnic University of Marche , Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","article-title":"Frequency and risk factors of gout flares in a large population-based cohort of incident gout","volume":"50","author":"Rothenbacher","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.semarthrit.2020.06.001","article-title":"The experience of a gout flare: a meta-synthesis of qualitative studies","volume":"50","author":"Stewart","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"J Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/acr.22844","article-title":"Development and first validation of a disease activity score for gout","volume":"68","author":"Scir\u00e8","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22741","article-title":"Development of preliminary remission criteria for gout using delphi and 1000minds consensus exercises","volume":"68","author":"de Lautour","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4281","article-title":"Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)","volume":"15","author":"Scire","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"e007214","DOI":"10.1136\/bmjopen-2014-007214","article-title":"Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims\u2013based analysis","volume":"5","author":"Jackson","year":"2015","journal-title":"BMJ Open"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3899\/jrheum.080487","article-title":"Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?","volume":"36","author":"Wu","year":"2009","journal-title":"J Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13075-019-1918-7","article-title":"Gout, flares, and allopurinol use: a population-based study","volume":"21","author":"Proudman","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"e0186096","DOI":"10.1371\/journal.pone.0186096","article-title":"Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study","volume":"12","author":"Abhishek","year":"2017","journal-title":"PLoS One"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/acr.22855","article-title":"Association of serum uric acid and disease duration with frequent gout attacks: a case\u2013control study","volume":"68","author":"Abhishek","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s42358-019-0075-7","article-title":"Clinical characteristics and risk factors for gout flare during the postsurgical period","volume":"59","author":"Jeong","year":"2019","journal-title":"Adv Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/annrheumdis-2019-216277","article-title":"Development of a prediction model for inpatient gout flares in people with comorbid gout","volume":"79","author":"Jatuworapruk","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10067-019-04566-6","article-title":"Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare","volume":"38","author":"Janssen","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"101595","DOI":"10.1016\/j.berh.2020.101595","article-title":"Imaging of crystalline arthropathy in 2020","volume":"34","author":"Filippucci","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-018-1714-9","article-title":"Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study: MSU burden and risk of gout flare","volume":"20","author":"Pascart","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2017-212046","article-title":"Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00393-020-00913-0","article-title":"Association of urate deposition shown by ultrasound and frequent gout attacks. Zusammenhang zwischen sonographisch darstellbarer Uratablagerung und h\u00e4ufigen Gichtanf\u00e4llen","volume":"80","author":"Zou","year":"2021","journal-title":"Z Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jbspin.2020.09.014","article-title":"UltraSound Evaluation in Follow-up of Urate-Lowering therapy in gout phase 2 (USEFUL-2): duration of flare prophylaxis","volume":"87","author":"Ebstein","year":"2020","journal-title":"Joint Bone Spine"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.joca.2021.01.007","article-title":"The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature review and meta-analysis","volume":"29","author":"Cipolletta","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"2023030119162673300_","first-page":"1194","article-title":"Identification of calcium pyrophosphate deposition disease (CPpower Doppler) by ultrasound: reliability of the OMERACT definitions in an extended set of joints\u2014an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force","volume":"77","author":"Filippou","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","volume":"78","author":"Bursill","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.40381","article-title":"Brief report: validation of a definition of flare in patients with established gout","volume":"70","author":"Gaffo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13075-021-02568-x","article-title":"Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study","volume":"23","author":"Cipolletta","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2013-203487","article-title":"Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout?","volume":"73","author":"Naredo","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbspin.2018.06.008","article-title":"The popliteal groove region: a new target for the detection of monosodium urate crystal deposits in patients with gout. An ultrasound study","volume":"86","author":"Di Matteo","year":"2019","journal-title":"Joint Bone Spine"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"e001144","DOI":"10.1136\/rmdopen-2019-001144","article-title":"Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy","volume":"6","author":"Christiansen","year":"2020","journal-title":"RMD Open"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1136\/annrheumdis-2017-211585","article-title":"The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology","volume":"76","author":"M\u00f6ller","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3899\/jrheum.150366","article-title":"Assessing elementary lesions in gout by ultrasound: results of an OMERACT patient-based agreement and reliability exercise","volume":"42","author":"Terslev","year":"2015","journal-title":"J Rheumatol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejrad.2006.12.005","article-title":"Impact of sonography in gouty arthritis: comparison with conventional radiography, clinical examination, and laboratory findings","volume":"62","author":"Schueller-Weidekamm","year":"2007","journal-title":"Eur J Radiol"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semarthrit.2018.02.009","article-title":"Serum urate as surrogate endpoint for flares in people with gout: a systematic review and meta-regression analysis","volume":"48","author":"Stamp","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/rheumatology\/keab283","article-title":"Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort","volume":"61","author":"Bajpai","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/annrheumdis-2021-220439","article-title":"Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan","volume":"80","author":"Koto","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/ard.2007.070755","article-title":"Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1093\/rheumatology\/keab335","article-title":"The inflammatory role of silent urate crystal deposition in intercritical gout","volume":"60","author":"Diaz-Torne","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/rheumatology\/keu157","article-title":"Prophylaxis for acute gout flares after initiation of urate-lowering therapy","volume":"53","author":"Latourte","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","article-title":"The British Society for Rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/keaa366","article-title":"Ultrasound for the diagnosis of gout\u2014the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group","volume":"60","author":"Christiansen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.semarthrit.2020.11.011","article-title":"Consensus-based semi-quantitative ultrasound scoring system for gout lesions: results of an OMERACT Delphi process and web-reliability exercise","volume":"51","author":"Christiansen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2023030119162673300_","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjmed.2018.11.011","article-title":"Adherence and outcomes with urate-lowering therapy: a site-randomized trial","volume":"132","author":"Mikuls","year":"2019","journal-title":"Am J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac367\/45277988\/keac367.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1108\/49355908\/keac367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1108\/49355908\/keac367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T03:20:05Z","timestamp":1700882405000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/3\/1108\/6654603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,3]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac367","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,8,3]]}}}